35.5605.98% ( -2.260 )
Delay Closed: Nov 16, 16:08:11Profile
About

INSILICO
03696.HK
InSilico Medicine Cayman TopCo engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms. The company offers Pharma.AI, an AI-powered drug discovery and development platform offering new target identification, small molecule generation, and clinical outcome prediction services. Its pipeline covers solutions for fibrosis, oncology, immunology, metabolic, anti-pain, and other therapeutic areas. The company is also involved in research and development collaboration, software solutions, business development, new drug discovery, and holding company businesses.
Profile
- Company Name
- InSilico Medicine Cayman TopCo
- Market
- SEHK
- Founded
- Industry
- --
- Fiscal Year End
- December 31
- Website
- insilico.com
Related Securities
Industry
Industry RankingsValueRank
Management
NamePosition
